Apologies, been busy, but yes attended an MST sponsored (i think) show and tell. I have some notes which i'll try to share over the next few days, however, MST will most likely have a note on CDX saying the same things.
All very positive, except delay in FDA approval. All the other vitals that will come out with Conneqt is a 1+1=5 scenario. We don't just measure the systolic and diastolic and try to provide health parameters - we also look at the waveform which tells a whole heap more. Which is why the company is able to release a many more bio-markers.
Anyway GLTAH - we're on the right bus.
General Forum, page-811
Add CDX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $35.30M | |||
| Open | High | Low | Value | Volume |
| 12.5¢ | 12.5¢ | 12.0¢ | $25.13K | 208.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 138695 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 281152 | 3 |
View Market Depth
| Last trade - 10.34am 19/11/2024 (20 minute delay) ? |
| CDX (ASX) Chart |